We are InfectoPharm

Monika and Dr. Manfred Zöller found InfectoPharm. Their vision: children need special medicines that taste good and are popular. InfectoPharm rapidly establishes itself in its newly created niche in the anti-infective market with just three antibiotic juices:

• InfectoCillin (1988) brings important advantages for doctors and patients: simple dosage, high concentration of active ingredients, better taste.
• InfectoMycin (1990) with further improved taste and better bioavailability, only needs to be taken twice daily.
• InfectoBicillin (1992) revolutionizes penicillin therapy in children with a very good taste and long half-life.

We take care of your questions! The consulting service for doctors, the consilium infectiorum, starts with six professors. Doctors get answers to their practical questions – fast, valid and product-independent.

Moving into the new, modern company building in Heppenheim

The premises are finally ready and we move our company headquarters from Weinheim to Heppenheim: 17 InfectoPharm employees move into the much larger and modern premises.

The main circular building is joined by another wing. Friendly offices, larger laboratories and a light-flooded staff restaurant, our “Treff”, set a new milestone.

SalbuBronch, the first oral salbutamol, is launched in 2007 to significantly simplify the treatment of obstructive bronchitis. Pediatricians rewarded this: in 2010 and 2011, it was voted the second most innovative product.

Our preparation InfectoDexaKrupp takes first place in 2011. The dexamethasone juice for croup attacks allows a child-friendly dosage and fulfills a need of the medical profession.

Shortly before Christmas 2011, company founder Dr. Manfred Zöller passes away unexpectedly at the age of 63. His two children, Anna and Philipp, succeed him as graduate pharmacists and fill the gap in the management alongside their mother Monika Zöller as well as Dr. Markus Rudolph and Dr. Norbert Stempel.

InfectoPharm employs 130 people and generates an annual turnover of 60 million euros. Our portfolio comprises 60 medicines for infectious diseases, asthma and neurodermatitis. Preparations for allergies will be added in 2012. From now on, not only pediatricians, dermatologists and ENT specialists, but also midwives, pharmacists and PTAs – as well as children, of course – will benefit from new products and additional services for doctors.

The utilization rate of the storage spaces in the warehouse, including the rented space, is over 95%. The management decides to build a new, state-of-the-art and fully automated logistics center, which will be put into operation in 2018. This reaffirms our long-standing ties with the town of Heppenheim.

On May 1, we took over the approval and distribution of the prescription drug portfolio of the Ritalin brand from Novartis. By far the largest project in the company’s history was fully integrated and implemented over the course of the year. We now distribute Ritalin in 19 countries.

After three years of construction, a new meeting place has grown in the center of the InfectoPharm Campus. Where the central warehouse used to be located, the conversion was as sustainable as possible: using natural materials and preserving the existing building fabric, the new offices were joined by other state-of-the-art multifunctional and meeting rooms and the new restaurant for all employees.

Today, InfectoPharm is a family-run pharmaceutical company in its second generation and stands for strategically successful investments on a broad basis and stable partnerships that have grown over the years. More than 400 employees in Heppenheim and a network of international cooperations achieve an increasing annual turnover of currently around 250 million euros.